kweetoknie schreef op 19 februari 2019 17:26:
quote:
beeldscherm schreef op 19 feb 2019 om 17:09:
FDA Cautions Over Young Donor Blood Transfusions to Treat Aging, Memory Loss
In a warning to consumers on Tuesday, the US Food and Drug Administration (FDA) said consumers should be cautious about establishments offering infusions of plasma obtained from young human donors with the claim that the infused plasma will prevent aging to memory loss.
..
FDA also notes establishments claiming that blood transfusions can prevent not only aging or memory loss, or for the treatment of such conditions as dementia, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, heart disease, or post-traumatic stress disorder.
www.raps.org/news-and-articles/news-a...dit is ZEEEERRR goed nieuws voor Pharmings Ruconest
De amateur schreef:
Is geen verband. Sterker nog minder gebruik van plasma voorkomt tekorten in sectoren waar het echt nodig is. Bijv de HAE medicatie op bloedbasis.
Oh nee? Heb je het stukje wel gelezen dan?
In a note to health care providers, the agency also said the FDA-recognized Circular of Information for the Use of Human Blood and Blood Components published by AABB lists the following indications for the administration of plasma:
Management of patients with rare specific plasma protein deficiencies, when recombinant products are unavailable.”
Lees ik het goed,... volgens de FDA zou je alleen bloedplasma moeten gebruiken als er geen recombinante (Ruconest) producten aanwezig zijn.